Welcome to the 8th Oncolytic Virotherapy Summit: Engineering Oncolytic Viruses Towards Revolutionary Anti-Cancer Immunotherapies Recent years have seen highly promising and...

Following proof of concept in oncology, misfolded and aggregated pathological proteins across CNS indications are the new frontier for protein degradation technologies. Heading...

With 2023 welcoming newly FDA-approved gene therapies from BioMarin, Krystal Biotech and Sarepta Therapeutics, many more treatments are hot on their heels for approval,...

Advance Scalability, Accessibility and Affordability of Autologous Cell Therapies As the cell therapy space bears witness to an increasing number of autologous therapies...

This conference will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to...

Following the success of the 3rd Annual Psychedelic Therapeutics and Drug Development Conference in 2023, we're thrilled to be hosting the 4th Annual event on May 23-24, 2024...